Identification of essential genes for cancer immunotherapy

Area of Science:

• Cancer research
• Immunology
• Genetics

Background:

• Somatic gene mutations can influence cancer cell susceptibility to T-cell immunotherapies.
• Understanding genetic alterations driving resistance is crucial for improving cancer treatment outcomes.

Purpose of the Study:

• To identify genes whose loss-of-function mutations confer resistance to T-cell immunotherapies.
• To elucidate the mechanisms by which specific gene mutations affect anti-tumor immunity.

Main Methods:

• Utilized a genome-scale CRISPR-Cas9 screen in human melanoma cells to identify genes critical for CD8+ T cell effector function.
• Validated candidate genes using various cancer cell lines and antigens.
• Investigated the role of identified genes in immunotherapy response using mouse models.

Main Results:

• Genes involved in antigen presentation and interferon-gamma signaling were significantly enriched in the screen.
• Loss-of-function mutations in APLNR (encoding the apelin receptor) were identified in immunotherapy-refractory tumors.
• APLNR interacts with JAK1, modulating interferon-gamma responses, and its loss impairs immunotherapy efficacy in vivo.

Conclusions:

• The study links the loss of essential genes for CD8+ T cell function to cancer's resistance to immunotherapy.
• APLNR mutations represent a potential mechanism of immunotherapy resistance.
• Targeting or understanding APLNR's role could inform strategies to overcome treatment non-responsiveness.